Document is current
Any future updates will be listed below
-
Authors
Wang, Danyang
Li, Bin
Shen, Guojie
Zhang, Hangyu
Gao, Yang
Du, Zhicheng
Dai, Xiaomeng
Bao, Xuanwen
Zhu, Xudong
Tong, Zhou
Hu, Dongxue
Liu, Lulu
Zheng, Yi
Zhao, Peng
Wang, Shu
Fang, Weijia
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Zhejiang Province (LMS25B050002)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0501600)
National Natural Science Foundation of China (52233013)
the "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province (2023C03061)
- License Information
-
More Information
Article History
Received: 13 July 2025
Accepted: 2 October 2025
First Online: 21 October 2025
Declarations
:
: S.W. holds employment and equity interest in Hangzhou CNK Therapeutics Co., Ltd. All other authors declare no competing interests.
: This study was approved by the Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University, and conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants.
